Kronox Lab Sciences Ltd
Incorporated in 2008, Kronox Lab Sciences Ltd manufactures High Purity Fine, inorganic chemicals, phosphate, and metallic chemicals[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit |
Ratios
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Exports as % of Revenue % ・Standalone data |
|
|||||
| Installed Capacity MTPA ・Standalone data |
||||||
| Number of Products Sold count ・Standalone data |
||||||
| Capacity Utilization % ・Standalone data |
||||||
| Number of Customers Served count ・Standalone data |
||||||
| Pharmaceutical Revenue Share % ・Standalone data |
||||||
| Production Volume MT ・Standalone data |
||||||
| Top 10 Customer Concentration % ・Standalone data |
||||||
Extracted by Screener AI
Documents
Announcements
-
Disclosure Under Regulations SEBI (LODR) - Amendment Ot The Share Purchase Agreement
- SPA amended on Oct 22, 2026; lock-in and ROFR removed for 64.26% share sale.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On October 14, 2026
- Board approved acquisition of 5,000 sq. m. plant in Dahej SEZ from Axiom Chemicals.
-
Acquisition Of A Plant Adm. About 5000 Sq. Meters Located In A Dahej SEZ From Axiom Chemicals Private Limited
- On Oct 14, 2026, Kronox approved acquisition of 5,000 sq. m Dahej SEZ plant from Axiom Chemicals.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Submitted Regulation 74(5) certificate for quarter ended 30 September 2026.
-
Disclosure Under Regulation 7(2) Of SEBI (PIT) Regulations, 2015 - Information And Update
- Oct. 1, 2026 disclosures reported sales of 23.09%, 23.09% and 18.09% stakes by three insiders.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
Business Overview:[1][2]
KLSL is in High Purity Speciality Fine Chemicals Business with portfolio of about 185 products including Excipients and ingredients, High Purity Reagents, Pharmaceutical, nutraceutical and Food Chemical.